STOCK TITAN

RNXT Form 4: 47,640 options granted to director Una S. Ryan

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

RenovoRx director Una S. Ryan was granted a stock option on 10/01/2025 to purchase 47,640 shares of common stock at an exercise price of $1.34 per share. The option vests in 12 equal monthly installments beginning 11/01/2025 and expires on 10/01/2035. Following the grant, Ms. Ryan directly beneficially owns 47,640 options. The Form 4 was signed on 10/02/2025 and shows the filing was made by a single reporting person.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
RYAN UNA S

(Last) (First) (Middle)
C/O RENOVORX, INC.
2570 W EL CAMINO REAL, SUITE 320

(Street)
MOUNTAIN VIEW CA 94040

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
RenovoRx, Inc. [ RNXT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
10/01/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Options (right to buy) $1.34 10/01/2025 A 47,640 (1) 10/01/2035 Common Stock 47,640 $0 47,640 D
Explanation of Responses:
1. The shares subject to the option vest in 12 equal monthly installments beginning on November 1, 2025.
/s/ Una S. Ryan 10/02/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did RenovoRx (RNXT) director Una S. Ryan report on Form 4?

Ms. Ryan reported an option grant dated 10/01/2025 to buy 47,640 shares at $1.34 per share.

When do the options granted to Una S. Ryan begin vesting?

The options vest in 12 equal monthly installments beginning on 11/01/2025.

What is the expiration date of the option grant reported for RNXT?

The option expires on 10/01/2035.

How many shares does the reported Derivative Security cover?

The reported derivative security covers 47,640 underlying shares of common stock.

Was the Form 4 filed jointly or by one reporting person?

The Form 4 was filed by one reporting person (individual filing).
Renovorx Inc

NASDAQ:RNXT

RNXT Rankings

RNXT Latest News

RNXT Latest SEC Filings

RNXT Stock Data

37.75M
33.05M
4.44%
24%
0.54%
Biotechnology
Pharmaceutical Preparations
Link
United States
MOUNTAIN VIEW